Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
CONJUGATES OF MAYTANSINOID DM1 WITH ANTIBODY TRASTUZUMAB, LINKED THROUGH A NON-CLEAVABLE LINKER, AND ITS USE IN THE TREATMENT OF TUMOURS

No-Receipt date 2013-03950 - 18/12/2013
No-Filing date 20130800059 - 18/12/2013
No-Granting date 8000485 - 07/10/2014
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 4/2014 - 15/05/2014
Gazette No-Publication date of granted patent 10/2014 - 21/11/2014
Expiration date 20/11/2028
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status VALID
Priorities US50990110/10/2003/US
US96060208/10/2004/US
Active Substance of Supplementary Certificates TRASTUZUMAB EMTANSINE

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20130400880

Owners
CodeFirstnameSurnameAddressTownZIPCountry
446011 IMMUNOGEN, INC. 830 WINTER STREETWALTHAM, MA 02451 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1155302RITA STEEVES
1155303ROBERT LUTZ
1155304RAVI CHARI
1155305YELENA KOVTUN

Representatives
CodeFirstnameSurnameAddressTownZip
742KONSTANTINOSKILIMIRISXATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528

Contact
CodeFirstnameSurnameAddressTownZipCountry
2119KONSTANTINOSKILIMIRISCHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528 GREECE

Owners History

Title Instruments
DateOperationDescreption
5/16/2016 12:00:00 AMΔιάφορες Μεταβολές (70004) Διόρθωση στην ημερομηνία λήξεως από: 16/11/2028 σε: 20/11/2028 σύμφωνα με την από 06/10/2015 απόφαση του Δικαστηρίου Ευρωπαικής Ένωσης σχετικά με την υπόθεση C-471/14.

Payments history 1 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).